|
| 36762756 | Prognostic Value of Low-Pass Whole Genome Sequencing of Circulating Tumor DNA in Metastatic Castration-Resistant Prostate Cancer. | Clin Chem | 2023 |
| 37292496 | <i>AR</i> and <i>PI3K</i> Genomic Profiling of Cell-free DNA Can Identify Poor Responders to Lutetium-177-PSMA Among Patients with Metastatic Castration-resistant Prostate Cancer. | Eur Urol Open Sci | 2023 |
| 35049068 | Ductal and acinar components of mixed prostatic adenocarcinoma frequently have a common clonal origin. | Prostate | 2022 |
| 35809752 | ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group. | Ann Oncol | 2022 |
| 35598857 | Translational in vitro and in vivo PKPD modelling for apramycin against Gram-negative lung pathogens to facilitate prediction of human efficacious dose in pneumonia. | Clin Microbiol Infect | 2022 |
| 35595235 | Transcriptome-wide prediction of prostate cancer gene expression from histopathology images using co-expression-based convolutional neural networks. | Bioinformatics | 2022 |
| 35317973 | Clinical Trial Protocol for ProBio: An Outcome-adaptive and Randomised Multiarm Biomarker-driven Study in Patients with Metastatic Prostate Cancer. | Eur Urol Focus | 2022 |
| 35251131 | Fusion Gene Detection Using Whole-Exome Sequencing Data in Cancer Patients. | Front Genet | 2022 |
| 35139729 | Circulating tumor DNA (ctDNA) in adjuvant therapy of early stage colon cancer: current status and future perspectives. | Acta Oncol | 2022 |
| 34393083 | Artificial Intelligence for Diagnosis and Gleason Grading of Prostate Cancer in Biopsies-Current Status and Next Steps. | Eur Urol Focus | 2021 |
| 33591326 | Challenging conventional karyotyping by next-generation karyotyping in 281 intensively treated patients with AML. | Blood Adv | 2021 |
| 33808193 | Increased Pathway Complexity Is a Prognostic Biomarker in Metastatic Castration-Resistant Prostate Cancer. | Cancers (Basel) | 2021 |
| 32354186 | Removing Critical Gaps in Chemical Test Methods by Developing New Assays for the Identification of Thyroid Hormone System-Disrupting Chemicals-The ATHENA Project. | Int J Mol Sci | 2020 |
| 31926806 | Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study. | Lancet Oncol | 2020 |
| 32586393 | The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancer. | Trials | 2020 |
| 32527994 | Integrated transcriptomic and genomic analysis improves prediction of complete remission and survival in elderly patients with acute myeloid leukemia. | Blood Cancer J | 2020 |
| 32281630 | Reply: Impact of first-line cancer treatment on follicle quality in cryopreserved ovarian samples. | Hum Reprod | 2020 |
| 32183364 | Inherited DNA Repair Gene Mutations in Men with Lethal Prostate Cancer. | Genes (Basel) | 2020 |
| 30844262 | Toxicokinetics of Perfluorinated Alkyl Acids Influences Their Toxic Potency in the Zebrafish Embryo ( Danio rerio). | Environ Sci Technol | 2019 |
| 30209161 | <i>TP53</i> Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer. | Clin Cancer Res | 2019 |
| 31411325 | Impact of first-line cancer treatment on the follicle quality in cryopreserved ovarian samples from girls and young women. | Hum Reprod | 2019 |
| 31265360 | Has the PROPHECY of AR-V7 Been Fulfilled? | J Clin Oncol | 2019 |
| 31194822 | Are Prostate Specific-Antigen (PSA) and age associated with the risk of ISUP Grade 1 prostate cancer? Results from 72 996 individual biopsy cores in 6 083 men from the Stockholm3 study. | PLoS One | 2019 |
| 31046065 | Androgen Receptor Burden and Poor Response to Abiraterone or Enzalutamide in TP53 Wild-Type Metastatic Castration-Resistant Prostate Cancer. | JAMA Oncol | 2019 |
| 31015488 | Gestational exposure to an epidemiologically defined mixture of phthalates leads to gonadal dysfunction in mouse offspring of both sexes. | Sci Rep | 2019 |
| 28881048 | A novel technique for biobanking of large sections of radical prostatectomy specimens. | Histopathology | 2018 |
| 30349339 | Plasma stearoyl-CoA desaturase activity indices and bile acid concentrations after a low-fat meal: association with a genetic variant in the <i>FTO</i> gene. | Diabetes Metab Syndr Obes | 2018 |
| 30458854 | Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis. | Genome Med | 2018 |
| 30274703 | Towards Next-generation Urine-based Prostate Cancer Risk Stratification. | Eur Urol | 2018 |
| 29625580 | Expression levels of long non-coding RNAs are prognostic for AML outcome. | J Hematol Oncol | 2018 |
| 29506270 | Development and Validation of a Novel RNA Sequencing-Based Prognostic Score for Acute Myeloid Leukemia. | J Natl Cancer Inst | 2018 |
| 29202480 | Differential impact of RB status on E2F1 reprogramming in human cancer. | J Clin Invest | 2018 |
| 29248446 | Cellular accumulation and lipid binding of perfluorinated alkylated substances (PFASs) - A comparison with lysosomotropic drugs. | Chem Biol Interact | 2018 |
| 29146461 | Resveratrol supports and alpha-naphthoflavone disrupts growth of human ovarian follicles in an in vitro tissue culture model. | Toxicol Appl Pharmacol | 2018 |
| 28753803 | The Stockholm-3 (STHLM3) Model can Improve Prostate Cancer Diagnostics in Men Aged 50-69 yr Compared with Current Prostate Cancer Testing. | Eur Urol Focus | 2018 |
| 27224670 | Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injury. | Liver Int | 2017 |
| 28167833 | Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profiling. | Leukemia | 2017 |
| 28457729 | Genetic profile of ductal adenocarcinoma of the prostate. | Hum Pathol | 2017 |
| 28104311 | Comprehensive Profiling of the Androgen Receptor in Liquid Biopsies from Castration-resistant Prostate Cancer Reveals Novel Intra-AR Structural Variation and Splice Variant Expression Patterns. | Eur Urol | 2017 |
| 28215847 | Prostate cancer screening in men aged 50 to 69 years (STHLM3): A prospective population-based diagnostic study. Grönberg H, Adolfsson J, Aly M, Nordström T, Wiklund P, Brandberg Y, Thompson J, Wiklund F, Lindberg J, Clements M, Egevad L, Eklund M.Lancet Oncol. 2015 Dec;16(16):1667-76. [Epub 2015 Nov 10]. doi: 10.1016/S1470-2045(15)00361-7. | Urol Oncol | 2017 |
| 28292578 | Corrigendum to "Integration of Copy Number and Transcriptomics Provides Risk Stratification in Prostate Cancer: A Discovery and Validation Cohort Study" [EBioMedicine 2 (9) (2015) 1133-1144]. | EBioMedicine | 2017 |
| 29151792 | Fluoxetine modulates sex steroid levels in vitro. | Clujul Med | 2017 |
| 29187174 | Intra-tumor heterogeneity in breast cancer has limited impact on transcriptomic-based molecular profiling. | BMC Cancer | 2017 |
| 28675654 | Bioinformatory-assisted analysis of next-generation sequencing data for precision medicine in pancreatic cancer. | Mol Oncol | 2017 |
| 27587435 | Molecular Differences between Screen-Detected and Interval Breast Cancers Are Largely Explained by PAM50 Subtypes. | Clin Cancer Res | 2017 |
| 27815082 | Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate Tumors. | Eur Urol | 2017 |
| 26950096 | Gene regulatory mechanisms underpinning prostate cancer susceptibility. | Nat Genet | 2016 |
| 27901097 | Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers. | Sci Rep | 2016 |
| 27959945 | The In Vitro Stability of Circulating Tumour DNA. | PLoS One | 2016 |
| 27165105 | Determining breast cancer histological grade from RNA-sequencing data. | Breast Cancer Res | 2016 |